Trial intelligence / Profile preview

Propofol-dexmedetomidine vs Isoflurane on Immune Function in Laryngectomy

NCT02739958Completed

Sponsor
Mansoura University
Start
Mar 2016
Primary completion
Aug 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of propofol injection (veterinary) and dexmedetomidine in laryngeal cancer (2 arms), sponsored by Mansoura University. Primary endpoint: CD3 plasma level at 7 days. Started Mar 2016; status: completed.

02

Drugs

propofol injection (veterinary)dexmedetomidine
03

Conditions

laryngeal cancer

Beyond the preview

Go deeper on NCT02739958.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02739958.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call